Employees: 11-50
Total raised: $15.97M
Founded date: 2018
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.06.2025 | - | $15.97M | - |
Mentions in press and media 11
| Date | Title | Description |
| 12.06.2025 | Spanish MedTech scale-up Aortyx spins spider-inspired tech to mend torn aortas – raising €13.8 million | Aortyx, a Barcelona-based MedTech scale-up, has raised a €13.8 million Series A funding round to reach the milestone of first-in-human testing, bringing their product – a bioresorbable patch that treats aortic tears – closer to market. The ... |
| 12.06.2025 | Aortyx secures €13.8M to bring life-saving vascular patch to humans | The Barcelona-based Aortyx has raised a €13.8 million Series A funding round led by Ship2B Ventures. The Aortyx team is developing a minimally invasive solution to what is called aortic dissection – essentially a tear in the aortic wall. To... |
| 23.04.2021 | Aortyx, participada por Genesis Ventures, cierra una ronda de €2,4 millones canalizada a través de Capital Cell | 23/04/2021 Nota de prensa AORTYX, PARTICIPADA POR GENESIS VENTURES, CIERRA UNA RONDA DE 2,4 MILLONES CANALIZADA A TRAVÉS DE CAPITAL CELL. Aortyx, una start-up nacida desde el Institut Químic de Sarrià y el Hospital Clínic de Barcelona, e... |
| 26.10.2020 | 21 start-ups reach EIT Health Catapult Final | Twenty-one start-ups from across Europe have secured their places at the EIT Health Catapult Final in December. The EIT Health Catapult, currently in its fifth year, is a training and competition programme that boosts the development of Eu... |
| 13.06.2020 | 42 start-ups reach EIT Health Catapult Semi-finals | The EIT Health Catapult, currently in its fifth year of operation, is a training and competition programme that boosts the development of European health start-ups by exposing them to top quality experts and international investors. The 42... |
| 06.03.2020 | Aortyx cierra una ronda de €650.000 liderada por Genesis Ventures | 06/03/2020 Nota de prensa AORTYX CIERRA UNA RONDA DE €650.000 LIDERADA POR GENESIS VENTURES. Aortyx, ‘spin-off’ del IQS especializada en la creación de dispositivos endovasculares para las disecciones aórticas, ha ampliado capital en 650... |
| 06.03.2020 | Aortyx obtains a 650,000€ capital increase | Aortyx, spin-off from IQS specialized in the creation of endovascular devices for aortic dissections, has started the year 2020 with a 650,000€ seed capital increase. Genesis Ventures is the lead investor among the 71 that Aortyx currently ... |
| - | Impulsar el cambio desde la infancia para romper la brecha de género en la ciencia | En el marco del Día de la Mujer en Ciencia hablamos con algunas de las emprendedoras de las startups IQS Tech Factory para conocer sus reflexiones y acciones clave para fomentar el papel de la mujer en el sector científico |
| - | Aortyx gana el premio Àlex Casta 2020 | Ona Therapeutics, Glycardial, ABLE Human Motion, Pebble Analytics y Aortyx son las 5 startups finalistas que han competido para llevarse el premio. |
| - | AORTYX CIMIENTA SU CRECIMIENTO CON UNA AMPLIACIÓN DE CAPITAL DE 650.000 EUROS | La spin-off de IQS desarrolla un dispositivo endovascular mínimamente invasivo para reducir la tasa de mortalidad en disecciones aórticas. La compañía cuenta con el apoyo de IQS Tech Factory y destaca por desarrollar su actividad sin necesi... |
Show more